Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1786717Generated: October 30, 2026

Imatinib → N-(4-Methyl-3-nitro-phenyl)-4-(4-methyl-piperazin-1-ylmethyl)-benzamide

https://huagongshe.com/reaction/1786717

Reaction equation

Participants

RoleNameHCIDCharge
ReactantImatinibHCID 5291—
Reactant4-Methyl-3-nitroanilineHCID 8390—
ReactantMethyl 4-((4-methylpiperazin-1-yl)methyl)benzoateHCID 782222—
ProductN-(4-Methyl-3-nitro-phenyl)-4-(4-methyl-piperazin-1-ylmethyl)-benzamideHCID 29984087—

Reaction Steps

U.S. Pat. No. 5,521,184 and application WO 03/066613 describe several synthetic routes for preparing Imatinib. One synthetic process, described in Scheme 1, comprises reacting 4-(4-methyl-piperazin-1-ylmethyl)-benzoic acid methyl ester with 3-nitro-4-methyl-aniline to obtain N-(4-methyl-3-nitrophenyl)-4-(4-methyl-piperazin-1-ylmethyl)-benzamide, which is subsequently reduced to obtain N-(3-amino-4-methyl-phenyl)-4-(4-methyl-piperazin-1-ylmethyl)-benzamide. The latter is reacted with cyanamide (NH2CN) in a mixture of concentrated hydrochloric acid solution and n-butanol to produce N-(3-guanidino-4-methyl-phenyl)-4-(4-methyl-piperazin-1-ylmethyl)-benzamide, which is subsequently reacted with 3-dimethylamino-1-pyridin-3-yl-propenone to obtain Imatinib.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07507821B2
Source datasetuspto-grants-2009_03
ORD IDord-416ea1cf0f1a47d29ae88e86e018323e
Source noteuspto-grants-2009_03